Product NewsFujirebio submits FDA regulatory filing for Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic test
Industry NewsBeckman Coulter and Fujirebio expand partnership to develop patient-friendly, blood-based neurodegenerative disease diagnostics
Product NewsFujirebio launches the fully automated Lumipulse G NfL CSF and Lumipulse G NfL Blood tests
Industry NewsAriBio Co., Ltd. and Fujirebio Diagnostics, Inc. partner to advance biomarker development for Alzheimer’s disease and neurodegeneration
Industry NewsFujirebio acquires Fluxus, a Silicon Valley-based innovation company in the biotechnology area
